Skip to main content

Table 1 Blood EV proteomics for inflammatory respiratory diseases

From: Proteomics of blood extracellular vesicles in inflammatory respiratory diseases for biomarker discovery and new insights into pathophysiology

References

Disease

Technology

MS mode

Feature

Biomarkers

Disease severity predicted by the biomarkers

Adduri, et al. [24]

ILD

LC–MS/MS

DDA

Diagnosis for IPF

SFTPB, ALDOA, HMGB1, CALML5, and TLN1

Diagnostic/classification use

Enomoto, et al. [25]

ILD

LC–MS/MS

DIA

Diagnosis for PPF

SFTPB

Unfavorable

Tomoto, et al. [26]

ILD

LC–MS/MS

DIA

Estimation of IPF‑specific protein network

-

-

Yoshimura, et al. [37]

BA

LC–MS/MS

DIA

Diagnosis for eosinophilic BA

Gal-10

Unfavorable

Koba, et al. [45]

COPD

LC–MS/MS

DDA

Diagnosis for COPD

Fibulin-3

Unfavorable

Jung, et al. [46]

COPD

EV array analysis

 

Diagnosis for acute exacerbation of COPD

CD45 and CD28

Diagnostic/classification use

Mao, et al. [60]

COVID-19

LC–MS/MS

DIA

Characteristics and residual traces of recovered COVID-19 patients

Proteins associated with coagulation activity, inflammatory reaction, immune response, and low organ function

Diagnostic/classification use

Krishnamachary, et al. [62]

COVID-19

PEA

-

Diagnosis of severe patients

TF, CD163, and EN-RAGE

Unfavorable

Fujita, et al. [61]

COVID-19

LC–MS/MS

DDA

Predictive biomarkers of severe patients

COPB2

Favorable

Lam, et al. [49]

COVID-19

LC–MS/MS

DDA

Proteomics change of different temporal stages of COVID-19

C1r, C1s

Diagnostic/classification use

Kawasaki, et al. [63]

COVID-19

LC–MS/MS

DIA

Predictive biomarkers of refractory patients

MACROH2A1

Unfavorable

Mehaffy, et al. [70]

M. tuberculosis

MRM-MS

-

Identification of peptides associated with LTBI

glutamine synthetase (GlnA1) enzyme

Diagnostic/classification use

Cheng, et al. [71]

Pediatric pneumonia

LC–MS/MS

DDA

Immune signatures of children with pneumonia

SERPINA1, ITIH4, IGLV6-57, HIST2H3A, HIST1H4, HIST1H2BL, COL1A1, ANXA2, COL2A1, ACAN, DSP, XP32, DSC1, HAPLN1, and DSG1

Diagnostic/classification use

  1. Abbreviations: ILD interstitial lung disease, IPF idiopathic pulmonary fibrosis, PPF progressive pulmonary fibrosis, BA bronchial asthma, COPD chronic obstructive pulmonary disease, LTBI latent tuberculosis infection, LC–MS/MS liquid chromatography with tandem mass spectrometry, MS mass spectrometry, PEA proximity extension analysis, DIA data-independent acquisition, DDA data-dependent acquisition